Pharmacological studies on hypotensive and spasmolytic activities of pure compounds from <i>Moringa oleifera</i>

Researchers isolated four specific compounds from moringa leaves and tested their effects on blood pressure and muscle contractions in laboratory animals and tissue samples. The compounds - niazinin A, niazinin B, niazimicin, and niaziminin A+B - all demonstrated significant cardiovascular effects when injected into anesthetized rats, lowering both blood pressure and heart rate. The team used bioassay-directed fractionation to extract these pure compounds from ethanolic moringa leaf extracts, then systematically tested them across multiple biological systems. In isolated guinea pig heart tissue, all four compounds reduced both the strength and rate of heart contractions. The compounds also relaxed various types of smooth muscle, including blood vessels, intestinal tissue, and uterine muscle, suggesting a broad mechanism of action. Importantly, the cardiovascular effects were not blocked by atropine, indicating the compounds work through pathways different from acetylcholine receptors. This finding helps explain why moringa has been traditionally used for digestive disorders, as the spasmolytic properties demonstrated in laboratory testing align with folk medicine applications. The research provides the first detailed pharmacological characterization of these specific moringa compounds, moving beyond crude extracts to identify the actual bioactive molecules responsible for cardiovascular and smooth muscle effects. This represents important progress in understanding the scientific basis for moringa's traditional medicinal uses, particularly for gastrointestinal motility problems.